Anand Rathi recommends a "Buy" on Gabriel India with a ₹1400 target, citing stro...
India’s manufacturing PMI for June held steady at 58.3, but business confidence ...
Akums Drugs, a mid-cap pharma stock, has surged 35% from April 2025 lows. Explor...
